Is There a Role for Use of Levonorgestrel Intrauterine System in Women with Chronic Pelvic Pain?
review
OA: closed
CC0
⤵ 10 in-corpus citations
AI-generated summary
This review examines the efficacy and safety of levonorgestrel intrauterine systems for managing chronic pelvic pain in women.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
This review focuses on the available evidence for the use of levonorgestrel (LNG) intrauterine system (IUS) in women with chronic pelvic pain (CPP). We have searched MEDLINE, Pubmed, Embase, and the Cochrane electronic library with the keywords "chronic pelvic pain," "endometriosis," "Mirena IUS," and "levonorgestrel IUS" from 1956 through April 2008. Review articles, randomized trials, prospective cohort studies, and retrospective studies were analyzed and the available evidence included in this review. Case reports were not included in the analysis. Laparoscopic surgery was shown to be useful in clarifying the underlying cause in women with CPP, with 70% having abnormal findings at laparoscopy. Endometriosis, particularly deep infiltrating endometriosis, is found in 40% to 60% of women with dysmenorrhea. Laparoscopic excision of endometriosis was shown to be associated with improvement of symptoms in 70% to 80% of women. Up to 36% need repeated surgery during a 5-year period after the primary procedure. The absolute reduction in recurrence of dysmenorrhea in women who also had the LNG IUS inserted at the time of surgery was 35% (95% CI 9%-61%). The LNG IUS was shown also to reduce the blood flow in the uterine artery and the subendometrial spiral arteries. This may explain the reduction in primary dysmenorrhea in women who have the LNG IUS inserted. Insertion of the LNG IUS at the time of primary laparoscopic surgery in women with CPP caused by endometriosis has the potential to reduce postoperative pain scores. This medical approach is also a promising alternative to repeated laparoscopic surgery especially in those women who have continuing symptoms after laparoscopic excision of endometriosis. This nonsurgical option could potentially reduce the rate of repeated laparoscopies in women with CPP and, in turn, reduce overall intervention rates. Although growing evidence exists that the LNG IUS can be useful in this group of women, large randomized controlled studies are needed to validate its benefits in day-to-day practice.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (25)
- Below the belt: approach to chronic pelvic pain. via openalex
- Chronic Pelvic Pain: Prevalence, Health-Related Quality of Life, and Economic Correlates via openalex
- Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study via openalex
- Diagnosis of Adenomyosis via openalex
- Diagnosis of adenomyosis: a review. via openalex
- Endometriosis via openalex
- Laparoscopic excision of endometriosis: A randomized, placebo-controlled trial via openalex
- Laparoscopic treatment of endometriosis improved pain and quality of life, but there was also a strong placebo effect via openalex
- Pain in endometriosis: effectiveness of medical and surgical management via openalex
- Progestogens for endometriosis: forward to the past via openalex
- The effects and effectiveness of laparoscopic excision of endometriosis: a prospective study with 2-5 year follow-up via openalex
- The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up via openalex
- The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease via openalex
- The role of the levonorgestrel-releasing intrauterine device in the management of symptomatic endometriosis via openalex
- Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis via openalex
- W6675728178 via openalex
- W2010233753 via openalex
- W2057022929 via openalex
- W2092026322 via openalex
- W1996855651 via openalex
- W2123134517 via openalex
- W1972123477 via openalex
- W4200472726 via openalex
- W4238358229 via openalex
- W2009355856 via openalex
Cited by (10)
- Effectiveness of hormonal intrauterine system in treatment of pelvic congestion syndrome compared to oral progestin 2025
- Endometriosis in Adolescent Girls 2020
- Surgical Management of Endometriosis 2020
- Benefícios não contraceptivos do Sistema Intrauterino Liberador de Levonorgestrel na endometriose 2015
- Abnormal bleeding in your female patient? Consider a progestin IUD Abnormal bleeding is common in women of childbearing age. For some, insertion of a levonorgestrel-releasing IUD—easily done in a family practice setting—may be all the treatment they need. 2014
- Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery 2013
- Hysterectomy and levonorgestrel-releasing intrauterine system in the treatment of menorrhagia : a 10-year randomized comparative trial 2012
- Hormonal contraceptives and endometriosis/adenomyosis 2010
- Induction of a local pseudo-pregnancy for the treatment of endometriosis 2009
- Induction of a local pseudo-pregnancy via levonorgestrel-loaded microspheres for the treatment of endometriosis in a rabbit model 2009
Source provenance
- europepmc
- last seen: 2026-08-04T06:16:37.499272+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:14:24.299271+00:00
- unpaywall
- last seen: 2026-06-05T02:00:03.366016+00:00
License: CC0
· commercial use OK